Virtual meeting
Via Zoom
Description
This training is designed to provide healthcare teams with information on all the available FDA-approved monthly/weekly injectable buprenorphine formulations used to treat opioid use disorder, as well as how to incorporate them into clinical practice.
Topics include the pharmacology and side effects of injectable buprenorphine formulations, storage, administration and patient selection processes, dosage, initiation and maintenance for patients using weekly and monthly injectable doses, and the workflows and administrative tasks involved in implementing injectable buprenorphine in healthcare settings.
NOTE: This training is 60 minutes long. There will be an optional 30-minute Q&A session following the training, which will not count for credit.
Intended audience
Physicians, advanced practice providers, nurses, social workers, recovery coaches, and all other healthcare professionals treating addiction are welcome and encouraged to attend.
Credits
NOTE: Please read the Accreditation Information section of the training event page to learn about the requirements for receiving credit or a certificate of completion
- CME (1.00)
- Nursing (1.00) ; Pharmacology (1.00)
- Social work (1.00)
- LADC (1.00)
- CADC (1.00)
- Recovery coach (1.00)
- LMHC (1.00)
Speakers
Jessica Kemp, RN, CARN (She/Her)
Emery Marcus, MSN, FNP-C, PMHNP-BC, CARN-AP
Objectives
1. Explain the pharmacology and side effects of injectable buprenorphine formulations.
2. Recall processes of patient selection, storage, and administration of injectable buprenorphine.
3. Develop a basic understanding of dosing, initiation, and maintenance using weekly and monthly injectable buprenorphine.
4. Identify workflows and administrative requirements for implementing injectable buprenorphine within healthcare settings.
Sponsored by
Boston Medical Center Grayken Center for Addiction TTA, Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)
Funding for out of state attendees is provided by the Opioid Response Network (ORN).
Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
